HealthVentureburnabout 2 hours ago

GT Medical Technologies Raises $100M Series E to Advance Brain Tumour Therapy

ByteBrief summary

4 min read

GT Medical Technologies raised $100 million in Series E funding led by Viking Global Investors to advance GammaTile brain tumour therapy. Funds support commercial rollout, clinical trial expansion, and operational growth. GammaTile delivers targeted radiation via bioresorbable collagen with Cesium-131 seeds during surgery, reducing recurrence and side effects.

Level

Hype check

Tap to vote and see what everyone thinks.

#gammatile #brain tumour #series e

Read full story

More to chew on!

Health1 day ago

Immuneel Raises ₹100 Cr for Global Gene Therapy Push

Chipsabout 9 hours ago

City Therapeutics Secures $99.5M Series B for RNAi

Climate